Table of Contents 1 Polymyositis Treatment Market Overview 1.1 Product Overview and Scope of Polymyositis Treatment 1.2 Classification of Polymyositis Treatment by Types 1.2.1 Global Polymyositis Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Polymyositis Treatment Revenue Market Share by Types in 2018 1.2.3 Immunosuppressant 1.2.4 Alkylating Agent 1.2.5 Immunoglobulin 1.2.6 Monoclonal Antibodies 1.2.7 Corticosteroids 1.3 Global Polymyositis Treatment Market by Application 1.3.1 Global Polymyositis Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Global Polymyositis Treatment Market by Regions 1.4.1 Global Polymyositis Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Polymyositis Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Polymyositis Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Polymyositis Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Polymyositis Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Polymyositis Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Polymyositis Treatment (2014-2024) 2 Company Profiles 2.1 Teva Pharmaceuticals 2.1.1 Business Overview 2.1.2 Polymyositis Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Teva Pharmaceuticals Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Novartis AG 2.2.1 Business Overview 2.2.2 Polymyositis Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Novartis AG Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Fresenius SE & Co. KGaA 2.3.1 Business Overview 2.3.2 Polymyositis Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Fresenius SE & Co. KGaA Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 Antares Pharma, Inc. 2.4.1 Business Overview 2.4.2 Polymyositis Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Antares Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Hospira, Inc. 2.5.1 Business Overview 2.5.2 Polymyositis Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Hospira, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 Medexus Pharma, Inc. 2.6.1 Business Overview 2.6.2 Polymyositis Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Medexus Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 Alcami Corporation 2.7.1 Business Overview 2.7.2 Polymyositis Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Alcami Corporation Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.8 Mylan N.V. 2.8.1 Business Overview 2.8.2 Polymyositis Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Mylan N.V. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.9 Genentech, Inc. 2.9.1 Business Overview 2.9.2 Polymyositis Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Genentech, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Polymyositis Treatment Market Competition, by Players 3.1 Global Polymyositis Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Polymyositis Treatment Players Market Share 3.2.2 Top 10 Polymyositis Treatment Players Market Share 3.3 Market Competition Trend 4 Global Polymyositis Treatment Market Size by Regions 4.1 Global Polymyositis Treatment Revenue and Market Share by Regions 4.2 North America Polymyositis Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Polymyositis Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Polymyositis Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Polymyositis Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Polymyositis Treatment Revenue and Growth Rate (2014-2019) 5 North America Polymyositis Treatment Revenue by Countries 5.1 North America Polymyositis Treatment Revenue by Countries (2014-2019) 5.2 USA Polymyositis Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Polymyositis Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Polymyositis Treatment Revenue and Growth Rate (2014-2019) 6 Europe Polymyositis Treatment Revenue by Countries 6.1 Europe Polymyositis Treatment Revenue by Countries (2014-2019) 6.2 Germany Polymyositis Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Polymyositis Treatment Revenue and Growth Rate (2014-2019) 6.4 France Polymyositis Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Polymyositis Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Polymyositis Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Polymyositis Treatment Revenue by Countries 7.1 Asia-Pacific Polymyositis Treatment Revenue by Countries (2014-2019) 7.2 China Polymyositis Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Polymyositis Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Polymyositis Treatment Revenue and Growth Rate (2014-2019) 7.5 India Polymyositis Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Polymyositis Treatment Revenue and Growth Rate (2014-2019) 8 South America Polymyositis Treatment Revenue by Countries 8.1 South America Polymyositis Treatment Revenue by Countries (2014-2019) 8.2 Brazil Polymyositis Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Polymyositis Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Polymyositis Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Polymyositis Treatment by Countries 9.1 Middle East and Africa Polymyositis Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Polymyositis Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Polymyositis Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Polymyositis Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Polymyositis Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Polymyositis Treatment Revenue and Growth Rate (2014-2019) 10 Global Polymyositis Treatment Market Segment by Type 10.1 Global Polymyositis Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Polymyositis Treatment Market Forecast by Type (2019-2024) 10.3 Immunosuppressant Revenue Growth Rate (2014-2024) 10.4 Alkylating Agent Revenue Growth Rate (2014-2024) 10.5 Immunoglobulin Revenue Growth Rate (2014-2024) 10.6 Monoclonal Antibodies Revenue Growth Rate (2014-2024) 10.7 Corticosteroids Revenue Growth Rate (2014-2024) 11 Global Polymyositis Treatment Market Segment by Application 11.1 Global Polymyositis Treatment Revenue Market Share by Application (2014-2019) 11.2 Polymyositis Treatment Market Forecast by Application (2019-2024) 11.3 Hospitals Revenue Growth (2014-2019) 11.4 Clinic Revenue Growth (2014-2019) 11.5 Others Revenue Growth (2014-2019) 12 Global Polymyositis Treatment Market Size Forecast (2019-2024) 12.1 Global Polymyositis Treatment Market Size Forecast (2019-2024) 12.2 Global Polymyositis Treatment Market Forecast by Regions (2019-2024) 12.3 North America Polymyositis Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Polymyositis Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Polymyositis Treatment Revenue Market Forecast (2019-2024) 12.6 South America Polymyositis Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Polymyositis Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Polymyositis Treatment Picture Table Product Specifications of Polymyositis Treatment Table Global Polymyositis Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Polymyositis Treatment Revenue Market Share by Types in 2018 Figure Immunosuppressant Picture Figure Alkylating Agent Picture Figure Immunoglobulin Picture Figure Monoclonal Antibodies Picture Figure Corticosteroids Picture Table Global Polymyositis Treatment Revenue (Million USD) by Application (2014-2024) Figure Polymyositis Treatment Revenue Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinic Picture Figure Others Picture Table Global Market Polymyositis Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Polymyositis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceuticals Polymyositis Treatment Type and Applications Table Teva Pharmaceuticals Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Novartis AG Basic Information, Manufacturing Base and Competitors Table Novartis AG Polymyositis Treatment Type and Applications Table Novartis AG Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Fresenius SE & Co. KGaA Basic Information, Manufacturing Base and Competitors Table Fresenius SE & Co. KGaA Polymyositis Treatment Type and Applications Table Fresenius SE & Co. KGaA Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors Table Antares Pharma, Inc. Polymyositis Treatment Type and Applications Table Antares Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Hospira, Inc. Basic Information, Manufacturing Base and Competitors Table Hospira, Inc. Polymyositis Treatment Type and Applications Table Hospira, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Medexus Pharma, Inc. Basic Information, Manufacturing Base and Competitors Table Medexus Pharma, Inc. Polymyositis Treatment Type and Applications Table Medexus Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Alcami Corporation Basic Information, Manufacturing Base and Competitors Table Alcami Corporation Polymyositis Treatment Type and Applications Table Alcami Corporation Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Mylan N.V. Basic Information, Manufacturing Base and Competitors Table Mylan N.V. Polymyositis Treatment Type and Applications Table Mylan N.V. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Genentech, Inc. Basic Information, Manufacturing Base and Competitors Table Genentech, Inc. Polymyositis Treatment Type and Applications Table Genentech, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Polymyositis Treatment Revenue (Million USD) by Players (2014-2019) Table Global Polymyositis Treatment Revenue Share by Players (2014-2019) Figure Global Polymyositis Treatment Revenue Share by Players in 2017 Figure Global Polymyositis Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Polymyositis Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Polymyositis Treatment Revenue Market Share in 2018 Figure Global Polymyositis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Polymyositis Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Polymyositis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Polymyositis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Polymyositis Treatment Revenue Market Share by Regions in 2018 Figure North America Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Europe Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure South America Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table North America Polymyositis Treatment Revenue by Countries (2014-2019) Table North America Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Polymyositis Treatment Revenue Market Share by Countries in 2018 Figure USA Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Canada Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table Europe Polymyositis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Polymyositis Treatment Revenue Market Share by Countries in 2018 Figure Germany Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure UK Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure France Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Russia Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Italy Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Polymyositis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Polymyositis Treatment Revenue Market Share by Countries in 2018 Figure China Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Japan Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Korea Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure India Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table South America Polymyositis Treatment Revenue by Countries (2014-2019) Table South America Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Polymyositis Treatment Revenue Market Share by Countries in 2018 Figure Brazil Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Polymyositis Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Polymyositis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Polymyositis Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure UAE Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Polymyositis Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Polymyositis Treatment Revenue and Growth Rate (2014-2019) Table Global Polymyositis Treatment Revenue (Million USD) by Type (2014-2019) Table Global Polymyositis Treatment Revenue Share by Type (2014-2019) Figure Global Polymyositis Treatment Revenue Share by Type (2014-2019) Figure Global Polymyositis Treatment Revenue Share by Type in 2018 Table Global Polymyositis Treatment Revenue Forecast by Type (2019-2024) Figure Global Polymyositis Treatment Market Share Forecast by Type (2019-2024) Figure Global Immunosuppressant Revenue Growth Rate (2014-2019) Figure Global Alkylating Agent Revenue Growth Rate (2014-2019) Figure Global Immunoglobulin Revenue Growth Rate (2014-2019) Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019) Figure Global Corticosteroids Revenue Growth Rate (2014-2019) Table Global Polymyositis Treatment Revenue by Application (2014-2019) Table Global Polymyositis Treatment Revenue Share by Application (2014-2019) Figure Global Polymyositis Treatment Revenue Share by Application (2014-2019) Figure Global Polymyositis Treatment Revenue Share by Application in 2018 Table Global Polymyositis Treatment Revenue Forecast by Application (2019-2024) Figure Global Polymyositis Treatment Market Share Forecast by Application (2019-2024) Figure Global Hospitals Revenue Growth Rate (2014-2019) Figure Global Clinic Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Polymyositis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Polymyositis Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Polymyositis Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Polymyositis Treatment Revenue Market Forecast (2019-2024) Figure Europe Polymyositis Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Polymyositis Treatment Revenue Market Forecast (2019-2024) Figure South America Polymyositis Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Polymyositis Treatment Revenue Market Forecast (2019-2024)

Teva Pharmaceuticals Novartis AG Fresenius SE & Co. KGaA Antares Pharma, Inc. Hospira, Inc. Medexus Pharma, Inc. Alcami Corporation Mylan N.V. Genentech, Inc.